https://scholars.lib.ntu.edu.tw/handle/123456789/639389
標題: | Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib | 作者: | Wu, Jia-Jun Tseng, Jeng-Sen Zheng, Zhe-Rong Chu, Cheng-Hsiang Chen, Kun-Chieh MONG-WEI LIN Huang, Yen-Hsiang Hsu, Kuo-Hsuan Yang, Tsung-Ying SUNG-LIANG YU JIN-SHING CHEN CHAO-CHI HO Chang, Gee-Chen |
關鍵字: | EGFR mutation; PD-L1; lung adenocarcinoma; osimertinib; primary tumor radiotherapy; primary tumor resection | 公開日期: | 2024 | 卷: | 16 | 來源出版物: | Therapeutic advances in medical oncology | 摘要: | Patients with advanced epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma (LAD) inevitably experience drug resistance following treatment with EGFR-tyrosine kinase inhibitors (TKIs). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/639389 | ISSN: | 1758-8340 | DOI: | 10.1177/17588359231220606 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。